Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64


Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.

Collins ND, Newbound GC, Albrecht B, Beard JL, Ratner L, Lairmore MD.

Blood. 1998 Jun 15;91(12):4701-7.


HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells.

Nicot C, Mulloy JC, Ferrari MG, Johnson JM, Fu K, Fukumoto R, Trovato R, Fullen J, Leonard WJ, Franchini G.

Blood. 2001 Aug 1;98(3):823-9.


In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein.

Fukumoto R, Andresen V, Bialuk I, Cecchinato V, Walser JC, Valeri VW, Nauroth JM, Gessain A, Nicot C, Franchini G.

Blood. 2009 Apr 16;113(16):3726-34. doi: 10.1182/blood-2008-04-146928. Epub 2008 Sep 12.


The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-I-associated disorders.

Waldmann TA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S179-85. Review.


Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein.

Koralnik IJ, Mulloy JC, Andresson T, Fullen J, Franchini G.

J Gen Virol. 1995 Aug;76 ( Pt 8):1909-16.


The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.

Dekaban GA, Peters AA, Mulloy JC, Johnson JM, Trovato R, Rivadeneira E, Franchini G.

Virology. 2000 Aug 15;274(1):86-93.


Generation of monoclonal antibodies to the rabbit interleukin-2 receptor alpha chain (CD25) and its distribution in HTLV-1-transformed rabbit T cells.

Kotani M, Yamamura Y, Tsudo M, Tamatani T, Kitamura F, Miyasaka M.

Jpn J Cancer Res. 1993 Jul;84(7):770-5.


Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus.

Niinuma A, Higuchi M, Takahashi M, Oie M, Tanaka Y, Gejyo F, Tanaka N, Sugamura K, Xie L, Green PL, Fujii M.

J Virol. 2005 Sep;79(18):11925-34.


A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.

Arp J, LeVatte M, Rowe J, Perkins S, King E, Leystra-Lantz C, Foung SK, Dekaban GA.

J Virol. 1996 Nov;70(11):7349-59.


Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta.

Jones KS, Akel S, Petrow-Sadowski C, Huang Y, Bertolette DC, Ruscetti FW.

J Immunol. 2005 Apr 1;174(7):4262-70.


Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site.

Mariner JM, Lantz V, Waldmann TA, Azimi N.

J Immunol. 2001 Feb 15;166(4):2602-9.


Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

Fukushima N, Nishiura Y, Nakamura T, Kohno S, Eguchi K.

Intern Med. 2007;46(7):347-51. Epub 2007 Apr 2.


Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.

Takatsuka N, Hasegawa A, Takamori A, Shimizu Y, Kato H, Ohashi T, Amagasa T, Masuda T, Kannagi M.

Int Immunol. 2009 Sep;21(9):1089-100. doi: 10.1093/intimm/dxp074. Epub 2009 Aug 4.


Subunit structure of the high and low affinity human interleukin-15 receptors.

Lehours P, Raher S, Dubois S, Guo J, Godard A, Jacques Y.

Eur Cytokine Netw. 2000 Jun;11(2):207-15.

Supplemental Content

Support Center